Company intelligence
amfAR
amfAR advances scientific discovery to improve global health, with an enduring commitment to ending the HIV epidemic.
About amfAR
amfAR is a leading nonprofit dedicated to advancing scientific discovery and transforming global health with a primary and enduring commitment to ending the HIV/AIDS epidemic. Serving as a catalyst for breakthrough science, amfAR supports innovative research in areas where viruses and the immune system play a defining role, including cancer, neurological conditions, autoimmune disorders, and other viral diseases. Through strategic investments, global research partnerships, and evidence-based policy leadership, amfAR helps accelerate discoveries that improve health and save lives. Since 1985, amfAR has raised more than $950 million and awarded in excess of 3,900 grants to scientists worldwide.
Verified activity
Signals from amfAR
5 published signals
Research & Knowledge
amfAR published the PEPFAR Pulse Report, a study tracking how shifted priorities and disruptions in U.S. global AIDS funding have disrupted HIV service delivery abroad.
Reported by amfAR
Strategy & Corporate Development
amfAR has expanded its research investments into areas such as cancer immunology, neurological disease, and autoimmune research.
Reported by Kyle Clifford
Presence & Recognition
amfAR hosted its sixth annual amfAR Gala Venezia on Sunday.
Reported by Kyle Clifford
Presence & Recognition
amfAR supporter Orlando Bloom will present Marina Abramovic with the Award of Inspiration at the amfAR Venice gala on September 6.
Reported by amfAR
Presence & Recognition
amfAR announced that a selection of auction items will be auctioned at the amfARVenezia event on September 6, featuring beauty, impact, and lifesaving biomedical research.
Reported by amfAR